Clinical Trial

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)

Name: Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG) — clinical trial record (NCT07272889)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

Drug-drug interaction study between Ethinyl Estradioll/Levonorgestrel and Bemnifosbuvir/Ruzasvir

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-11-26.

Status change: Not Yet Recruiting → Completed 2026-04-08

Trial Details

NCT Number	NCT07272889
Lead Sponsor	Atea Pharmaceuticals, Inc.
Conditions	Healthy Volunteer Study
Enrollment	24 participants
Start Date	2025-12-04
Primary Completion	2026-02-17 (estimated)
Study Completion	2026-02-17 (estimated)
Updated on ClinicalTrials.gov	2026-04-13